Kathy Grange and Colin Nichols have received a 2-year NIH award to prepare for a full clinical trial of sulfonylurea drugs as therapy for Cantu Syndrome. This award will support efforts, through the WU Cantu Research Clinic, to validate clinical measures that will be used to assess benefit of drugs that directly counter the overactive ion channels that cause Cantu syndrome.
Getting ready for Clinical Trials
View Content